Sep. 13, 2017—Dr. Levi Garraway, senior vice president for global development and medical affairs for Lilly Oncology, will present the 16th annual Levi Watkins Jr., M.D., Lecture Oct. 10.
Aug. 22, 2016—Vanderbilt University Medical Center (VUMC) has been named to the 2016 Becker’s Hospital Review list of 100 Hospitals and Health Systems with Great Oncology Programs. The annual list recognizes organizations leading the nation in cancer care.
Oct. 24, 2014—1,165 budding programmers are participating in the university’s first MOOC capstone project – one that will result in a certificate for graduates and better pain management for patients at Vanderbilt University Medical Center.
Nov. 9, 2012—Patrick Grohar came to Vanderbilt in January from the National Cancer Institute, bringing with him his passions and self-motivation for lab-based work. His research focuses on drug discovery in pediatric sarcomas, cancers that develop in bone and soft tissues.
Cancer research and education agreement announced between Baptist Memorial Health Care and Vanderbilt University
Oct. 29, 2012—Executives with Baptist Memorial Health Care Corporation in Memphis, Tenn., and Vanderbilt University Medical Center today announced an academic affiliation agreement — paving the way for new clinical research and academic education opportunities that are designed to enhance cancer programs. The new affiliation establishes a framework for collaborative oncology initiatives between Baptist Cancer Center and...
Oct. 18, 2012—The 10th floor of Vanderbilt University Medical Center’s Critical Care Tower, housing a new myelosuppression unit, will open Oct. 27. The Critical Care Tower, an 11-story, 329,000-square-foot addition to Vanderbilt University Hospital (VUH), originally opened in 2009 with 12 operating rooms and three patient care units. Four floors were shelled for future growth, and the...
Sep. 21, 2012—A protein associated with aggressive breast cancers may also influence resistance of lung cancer to targeted therapies.
Mar. 2, 2012—New details on the DNA-cutting activity of topoisomerase II, a target of anti-cancer drugs, could lead to better chemotherapeutic agents.
Feb. 23, 2012—Investigators from Vanderbilt-Ingram Cancer Center and 12 other centers in the United States and Australia have found that a new drug for patients with metastatic melanoma nearly doubled median overall survival.
Nov. 11, 2011—Providing increased mentorship, research opportunities and a nurturing, intellectual environment during fellowship training may help reduce a projected shortage of academic hematologists and oncologists.
Jun. 30, 2011—Helicobacter pylori, a bacterium that infects half of the world’s population and increases the risk for stomach cancer, appears to impair nutrient absorption.
Jun. 29, 2011—Blocking a certain protein during radiation to treat brain cancers could protect the brain’s thinking powers.